You are viewing: France Life Science Instrumentation Market analysis

The France Life Science Instrumentation Market was valued at $4335.1 Million in 2025 and projected to reach to $6363.6 Million by 2030, representing a compound annual growth rate of CAGR 6.6%. France's life science instrumentation market is positioned for sustained growth through 2030, driven by increasing investments in pharmaceutical research, biotechnology development, and diagnostic capabilities.

France Life Science Instrumentation Market Trends and Insights

  • Japan's advanced healthcare infrastructure and strong pharmaceutical research capabilities drive demand for sophisticated laboratory and diagnostic instruments.
  • The market in Japan benefits from significant investment in biotechnology research, aging population demographics requiring advanced diagnostics, and the country's leadership in precision medicine and genomic sequencing technologies. The life science instrumentation sector in Japan is characterized by high adoption rates of cutting-edge analytical and diagnostic equipment across academic institutions, pharmaceutical companies, and clinical laboratories.
  • Japan's commitment to innovation in life sciences, coupled with government support for research and development initiatives, positions the country as a key market within Asia Pacific.
  • Between 2025 and 2030, Japan's market expansion will be supported by increasing healthcare expenditure, rising prevalence of chronic diseases, and growing demand for personalized medicine solutions..

Key Market Statistics

  • CAGR (2025-2030) CAGR 6.6%
  • Market Size, 2025 ~USD 4335.1 Million
  • Forecast, 2030 ~USD 6363.6 Million
  • Country France

France Life Science Instrumentation Market Overview

Strong Market Growth :

France's life science instrumentation market is valued at $4,335.1 million in 2025 and is projected to reach $6,363.6 million by 2030, with a CAGR of 6.6%, outpacing the global average of 6.5%.

Pharmaceutical Research Hub :

France hosts a robust pharmaceutical and biotechnology sector with significant R&D investments, driving demand for advanced laboratory instruments and diagnostic equipment across research institutions and clinical facilities.

Healthcare Infrastructure Excellence :

France's world-class healthcare system and well-established medical research ecosystem support continuous adoption of cutting-edge life science instrumentation in hospitals, universities, and private research centers.

Regulatory and Innovation Support :

Strong government support for life sciences innovation, combined with EU regulatory frameworks, encourages investment in modern instrumentation and attracts international biotech companies to establish operations in France.

France Life Science Instrumentation Market Dynamics

  • The country's commitment to life sciences innovation, supported by government initiatives and EU funding programs, creates favorable conditions for market expansion.
  • Healthcare modernization efforts and the growing prevalence of chronic diseases further accelerate demand for advanced laboratory and diagnostic instruments.
  • France's strategic position as a European life sciences hub ensures continued market momentum and attracts both domestic and international players seeking to expand their presence in the region..

Related Ecosystem

Analytical And Scientific Instrumentation

Top Technologies
  • Environmental Testing
  • Gas Chromatography
  • Polymerase Chain Reaction (PCR)
  • Automated Liquid Handling Systems
  • Flow Cytometry
Top Companies
  • Thermo Fisher Scientific Inc.
  • Danaher Corporation
  • Agilent Technologies, Inc.
  • Shimadzu Corporation
  • Merck KGaA

    Key Takeaways

    • Japan's life science instrumentation market will grow from $4,335.1M (2025) to $6,363.6M (2030) at a 6.6% CAGR.
    • Japan's aging population and advanced healthcare system drive strong demand for diagnostic and analytical instruments.
    • Government R&D investment and biotechnology initiatives position Japan as a regional innovation leader in life sciences.
    • Japan's market growth is supported by increasing adoption of precision medicine and genomic sequencing technologies through 2030.

    Life Science Instrumentation Market Report Scope

    Report Metric Details
    Base Year 2025
    Fastest Growing Segment NEXT-GENERATION SEQUENCING (NGS) (Type)
    Forecast Period 2025–2030
    Growth Rate CAGR of 6.5% from 2025 to 2030
    Largest Segment RESEARCH APPLICATION (Application)
    Market Size Base Year (Billions) ~USD 63.39 (2025)
    Revenue Forecast (Billions) ~USD 86.85 (2030)
    Segments Covered Technology, Type, Application, End User

    France Life Science Instrumentation Market Report Segmentation

    4 segment dimensions are covered across the global market.

    By Technology

    • Cell Counting
    • Centrifuges
    • Chromatography
    • Clinical Chemistry Analyzers
    • Electrophoresis
    • Flow Cytometry
    • Immunoassays
    • Liquid Handling Systems
    • Lyophilization
    • Microscopy
    • Next Generation Sequencing (Ngs)
    • Next-Generation Sequencing (Ngs)
    • Ngs
    • Other Technologies
    • Pcr
    • Polymerase Chain Reaction
    • Spectroscopy

    By Type

    • Atomic Spectrometers
    • Automated Cell Counters
    • Automated Handling Systems
    • Automated Liquid Handling Systems
    • Capillary Electrophoresis Systems
    • Cell Analyzers
    • Cell Sorters
    • Colorimeters
    • Conductivity And Resistivity Meters
    • Dissolved Co2 And O2 Meters
    • Dpcr
    • Dry Heat Sterilization Instruments
    • Electron Handling Systems
    • Electron Microscopes
    • Electronic Liquid Handling Systems
    • Freezers
    • Fume Hoods
    • Gas Analyzers
    • Gas Chromatography (Gc) Systems
    • Gas Chromatography Systems
    • Gel Electrophoresis Systems
    • Heat Sterilization
    • Hemocytometers And Manual Cell Counters
    • Incubators
    • Laboratory Balances
    • Laboratory Freezers
    • Liquid Chromatography (Lc) Systems
    • Liquid Chromatography Systems
    • Manifold Freeze Dryer
    • Manifold Freeze Dryers
    • Manual Handling Systems
    • Manual Liquid Handling Systems
    • Mass Spectrometers
    • Microcentrifuges
    • Microplate Dispensers
    • Microplate Readers
    • Microplate Systems
    • Microplate Washers
    • Minicentrifuges
    • Moist Heat/Steam Sterilization Instruments
    • Molecular Spectrometers
    • Multipurpose Centrifuges
    • Optical Microscopes
    • Other Microscopes
    • Ph Meters
    • Qpcr
    • Refrigerators
    • Robotic Arms
    • Robotic Systems
    • Scanning Probe Microscopes
    • Shakers/Rotators And Stirrers
    • Shell (Rotary) Freeze Dryer
    • Shell (Rotary) Freeze Dryers
    • Supercritical Fluid Chromatography (Sfc) Systems
    • Supercritical Fluid Chromatography Systems
    • Thermal Analyzers
    • Thin-Layer Chromatography (Tlc) Systems
    • Thin-Layer Chromatography Systems
    • Titrators
    • Toc Analyzers
    • Track Robot Systems
    • Tray-Style Freeze Dryer
    • Tray-Style Freeze Dryers
    • Ultracentrifuges

    By Application

    • Clinical & Diagnostic Applications
    • Other Applications
    • Research Application
    • Research Applications

    By End User

    • Academic & Research Institutes
    • Agriculture & Food Industries
    • Clinical Research Organizations
    • Environmental Testing Laboratories
    • Hospitals And Diagnostic Laboratories
    • Other End Users
    • Pharmaceutical & Biotechnology Companies

    Target Audience

    • Life Science Equipment Manufacturers : Manufacturers need France-specific market data to assess market potential, identify growth opportunities, and develop localized product strategies for the French pharmaceutical and research sectors.
    • Pharmaceutical & Biotech Companies : R&D leaders require insights into instrumentation market trends and capabilities to optimize laboratory investments, procurement decisions, and research infrastructure planning in France.
    • Healthcare Facility Administrators : Hospital and diagnostic center managers need market intelligence to evaluate instrumentation options, budget planning, and technology upgrades aligned with France's healthcare modernization initiatives.
    • Investment & Private Equity Firms : Investors evaluating opportunities in France's life sciences sector require detailed market sizing, growth projections, and competitive analysis to support investment decisions and portfolio strategy.
    • Market Research & Consulting Professionals : Analysts and consultants need comprehensive France market data to support client advisory services, competitive benchmarking, and strategic recommendations in the life science instrumentation space.

    Key Companies in the France Life Science Instrumentation Market

    CompanyHQOwnershipStrongest segments
    PATHEON INCNetherlandsPrivate CompanyDrug product services (finished dosage manufacturing & packaging),Pharmaceutical development services,Drug substance services (API and biologics),
    ABCAM PLCUnited KingdomPrivate CompanyPrimary and secondary antibodies,Conjugated antibodies and conjugation kits,Singleplex immunoassays,
    BECKMAN COULTERUnited StatesPrivate CompanyClinical diagnostics (chemistry, immunoassay, hematology, urinalysis, blood banking),Laboratory automation and informatics,Research and discovery instruments and services,
    CONSORT MEDICALUnited KingdomPrivate CompanyInhalation devices (DPIs, pMDIs, soft-mist) and related services,Injectable and autoinjector platforms,Nasal and other specialty delivery devices,
    ROCHE HOLDING AGSwitzerlandPublic CompanyOncology and hematology therapeutics,Immunology, infectious, and autoimmune therapeutics,Neurology, ophthalmology, respiratory, and transplantation,
    TOSOH CORPORATIONJapanPublic CompanyBasic chemicals and chlor-alkali (caustic soda, sodium bicarbonate, related),Vinyls, petrochemicals, and polymers (VCM, PVC, polyethylene, EVA, synthetic rubbers),Advanced materials (battery materials, quartzware, silica glass, thin films, zeolites, zirconia, fine beads),
    METTLER-TOLEDOSwitzerlandPublic CompanyLaboratory instruments & analytics (balances, titrators, pH, thermal, UV/VIS, moisture, cell counting),Industrial instruments (weighing, terminals, product inspection, industrial software),Retail weighing & fresh-goods solutions,
    CEPHEID INC.United StatesPrivate CompanyGeneXpert instruments,Xpert test cartridges – infectious disease & HAIs,Xpert test cartridges – TB and global health,
    AT&SCanadaPublic CompanyIntegrated automation systems (design-build-commissioning),Lifecycle and post-automation services,Software and digital factory solutions,
    UNILABSSwitzerlandPrivate CompanyCore laboratory testing,Medical imaging,Pathology and centres of excellence,
    DKK-TOA CORPORATIONJapanPublic CompanyWater quality analyzers and integrated monitoring systems,Process analyzers for industrial and refinery applications,Ambient air and emission gas analyzers,
    GENERAL ELECTRICUnited StatesPublic CompanyCommercial Engines OE,Commercial MRO & Spare Parts,Defense & Propulsion OE,
    THERMO FISHER SCIENTIFIC INC.United StatesPublic CompanyLife Sciences Solutions,Analytical Instruments,Specialty Diagnostics,
    AGILENT TECHNOLOGIES, INC.United StatesPublic CompanyLife Sciences and Diagnostics Markets,Agilent CrossLab,Applied Markets,
    DANAHER CORPORATIONUnited StatesPublic CompanyBiotechnology (bioprocessing and related solutions),Life Sciences (tools, genomics, and analytical instruments),Diagnostics (clinical instruments, consumables, software, services),
    SHIMADZU CORPORATIONJapanPublic CompanyAnalytical and Measuring Instruments,Medical Systems,Vacuum and Industrial Machinery,
    WATERS CORPORATIONUnited StatesPublic CompanyLiquid Chromatography Systems and Columns,Mass Spectrometry Systems,Thermal Analysis, Rheometry, and Calorimetry (TA segment),
    BRUKER CORPORATIONUnited StatesPublic CompanyBSI BioSpin (NMR/EPR and preclinical imaging),BSI CALID (mass spectrometry, molecular diagnostics, automation),BSI Nano (X-ray, AFM, electron microscopy tools),
    JEOL LTD.JapanPublic CompanyScientific and Metrology Instruments,Industrial Equipment,Medical Equipment,
    MERCK KGAAGermanyPublic CompanyLife Science (tools, reagents, bioprocessing, CDMO),Healthcare (prescription drugs and biopharmaceuticals),Electronics (semiconductor and display materials, delivery systems),
    BECTON, DICKINSON AND COMPANYUnited StatesPublic CompanyMedical Essentials (syringes, needles, catheters, sharps, basic disposables),Connected Care (infusion pumps, medication management, pharmacy automation, informatics),BioPharma Systems (prefillable drug delivery systems and related solutions),
    PERKINELMERUnited StatesPublic CompanyDiagnostics (prenatal, neonatal, infectious disease, autoimmune),Life science reagents and assay platforms,Instruments, imaging, and detection systems,
    BIO-RAD LABORATORIES, INC.United StatesPublic CompanyClinical Diagnostics,Life Science Research Instruments and Systems,Life Science Reagents and Consumables,
    EPPENDORF SEGermanyPrivate CompanyLiquid handling (pipettes, dispensers, automated pipetting),Separation & instrumentation (centrifuges, PCR cyclers, ULT freezers),Bioprocess solutions (fermenters, bioreactors, single-use bioreactors),
    HORIBA, LTD.JapanPublic CompanyMobility and transportation test systems,Energy and environment analyzers,Bio and healthcare (life science + IVD),
    QIAGENNetherlandsPublic CompanySample technology consumables and instruments,Immune response (TB and transplant/viral load assays),Oncology and sexual & reproductive health assays,
    HITACHI HIGH-TECH CORPORATIONJapanPrivate CompanyAnalytical & Medical Solutions (microscopes, clinical analyzers, chromatography, spectrometry),Nano-Technology Solutions (dry etch, CD-SEM, wafer inspection, FPD and HDD tools),Industrial Solutions (ICT, industrial infrastructure, energy, control systems),

    PATHEON INC

    Patheon Inc. is a Netherlands-based pharmaceutical services company with 9,100 employees operating as a private company. The company provides contract manufacturing and development services to the pharmaceutical industry.

    ABCAM PLC

    Abcam PLC is a United Kingdom-based life sciences company founded in 1998 with 1,760 employees. Operating as a private company, Abcam specializes in providing research tools and reagents for the scientific community.

    BECKMAN COULTER

    Beckman Coulter is a United States-based company founded in 1935 with 11,900 employees operating as a private company. The company manufactures and distributes laboratory instruments and diagnostic equipment.

    CONSORT MEDICAL

    Consort Medical is a United Kingdom-based private company founded in 1938 with 2,000 employees. The company manufactures and distributes medical devices and pharmaceutical delivery systems.

    ROCHE HOLDING AG

    Roche Holding AG is a Switzerland-based public company founded in 1896 with 103,249 employees. The company is a global leader in pharmaceuticals, diagnostics, and life sciences research.

    TOSOH CORPORATION

    Tosoh Corporation is a Japan-based public company founded in 1935 with 14,850 employees. The company manufactures specialty chemicals, pharmaceuticals, and diagnostic products.

    METTLER-TOLEDO

    Mettler-Toledo is a Switzerland-based public company founded in 1991 with 16,600 employees. The company designs and manufactures precision instruments for laboratory, industrial, and retail applications.

    CEPHEID INC.

    Cepheid Inc. is a United States-based private company founded in 1996 with 1,700 employees. The company develops and manufactures molecular diagnostic systems and tests.

    AT&S

    AT&S is a Canada-based public company founded in 1978 with 7,000 employees. The company manufactures printed circuit boards and electronic components.

    UNILABS

    Unilabs is a Switzerland-based private company founded in 1987 with 1,897 employees. The company provides clinical laboratory and diagnostic testing services.

    DKK-TOA CORPORATION

    DKK-TOA Corporation is a Japan-based public company founded in 1944 with 639 employees. The company manufactures water quality measurement and analysis instruments.

    GENERAL ELECTRIC

    General Electric is a United States-based public company founded in 1892 with 57,000 employees. The company operates across multiple sectors including power, renewable energy, aviation, and healthcare.

    THERMO FISHER SCIENTIFIC INC.

    Thermo Fisher Scientific Inc. is a United States-based public company founded in 1956 with 125,000 employees. The company is a global leader in life sciences, analytical instruments, and laboratory services.

    AGILENT TECHNOLOGIES, INC.

    Agilent Technologies, Inc. is a United States-based public company founded in 1999 with 18,000 employees. The company manufactures analytical instruments, software, and services for life sciences and diagnostics.

    DANAHER CORPORATION

    Danaher Corporation is a United States-based public company founded in 1969 with 59,000 employees. The company operates a diversified portfolio of businesses in diagnostics, life sciences, and environmental solutions.

    SHIMADZU CORPORATION

    Shimadzu Corporation is a Japan-based public company founded in 1875 with 14,649 employees. The company manufactures analytical and measuring instruments, medical devices, and industrial equipment.

    WATERS CORPORATION

    Waters Corporation is a United States-based public company founded in 1958 with 7,900 employees. The company designs and manufactures analytical instruments and software for laboratory analysis.

    BRUKER CORPORATION

    Bruker Corporation is a United States-based public company founded in 1960 with 11,085 employees. The company manufactures scientific instruments for molecular and materials research.

    JEOL LTD.

    JEOL Ltd. is a Japan-based public company founded in 1949 with 3,731 employees. The company manufactures electron microscopes and analytical instruments for scientific research.

    MERCK KGAA

    Merck KGaA is a Germany-based public company founded in 1668 with 59,077 employees. The company operates in pharmaceuticals, life sciences, and performance materials.

    BECTON, DICKINSON AND COMPANY

    Becton, Dickinson and Company is a United States-based public company founded in 1897 with 72,000 employees. The company manufactures and distributes medical devices, laboratory equipment, and diagnostic products.

    PERKINELMER

    PerkinElmer is a United States-based public company founded in 1937 with 11,000 employees. The company provides analytical instruments, software, and services for diagnostics and life sciences research.

    BIO-RAD LABORATORIES, INC.

    Bio-Rad Laboratories, Inc. is a United States-based public company founded in 1952 with 7,450 employees. The company manufactures and distributes life science research products and clinical diagnostics.

    EPPENDORF SE

    Eppendorf SE is a Germany-based private company founded in 1945 with 4,358 employees. The company manufactures laboratory equipment and consumables for life sciences research.

    HORIBA, LTD.

    Horiba, Ltd. is a Japan-based public company founded in 1945 with 9,101 employees. The company manufactures analytical and measuring instruments for automotive, environmental, and medical applications.

    QIAGEN

    QIAGEN is a Netherlands-based public company founded in 1984 with 5,500 employees. The company develops and manufactures molecular diagnostics and life sciences products.

    HITACHI HIGH-TECH CORPORATION

    Hitachi High-Tech Corporation is a Japan-based private company founded in 1947 with 11,482 employees. The company manufactures analytical instruments, semiconductor equipment, and industrial systems.

    Reasons to Buy this Report

    • Market Size & Growth Data : Access precise valuation of France's life science instrumentation market with detailed CAGR analysis, enabling accurate financial forecasting and investment planning specific to the French market.
    • Competitive Landscape Intelligence : Understand market dynamics, key players, and competitive positioning within France's life science sector to identify opportunities for market entry, partnerships, or expansion strategies.
    • Sector-Specific Insights : Gain detailed analysis of pharmaceutical research, diagnostic, and laboratory instrumentation segments within France, including growth drivers and emerging technology adoption trends.
    • Strategic Decision Support : Leverage comprehensive France-specific data to support business strategy, resource allocation, and go-to-market planning for life science instrumentation products and services.
    • Regulatory & Market Context : Understand France's healthcare infrastructure, regulatory environment, and innovation ecosystem to navigate market entry and optimize product positioning for French customers.

    Frequently asked questions

    What is the current size of Japan's life science instrumentation market?

    Japan's life science instrumentation market is valued at $4,335.1 million in 2025.

    What is the projected market size for Japan by 2030?

    Japan's life science instrumentation market is projected to reach $6,363.6 million by 2030.

    What is the CAGR for Japan's life science instrumentation market?

    Japan's life science instrumentation market is expected to grow at a compound annual growth rate of 6.6% from 2025 to 2030.

    What factors are driving growth in Japan's life science instrumentation market?

    Key growth drivers in Japan include an aging population, advanced healthcare infrastructure, government R&D investment, increasing adoption of precision medicine, and strong pharmaceutical research capabilities.

    How does Japan's market compare to other Asia Pacific countries?

    Japan represents a significant portion of the Asia Pacific life science instrumentation market, driven by its advanced technology adoption, high healthcare spending, and leadership in biotechnology innovation.

    RESEARCH METHODOLOGY

    The study involved four major activities in estimating the current size of the life science instrumentation market. Exhaustive secondary research was done to collect information on the market, peer, and parent markets. The next step was to validate these findings, assumptions, and sizing estimates with industry experts across the value chain through primary research. Both top-down and bottom-up approaches were employed to estimate the complete market size. After that, market breakdown and data triangulation were used to estimate the market size of segments and subsegments.

    Secondary Research

    The secondary research process involves the widespread use of secondary sources, directories, databases (such as Bloomberg Businessweek, Factiva, and D&B Hoovers), white papers, annual reports, company house documents, investor presentations, and SEC filings of companies. Secondary research was used to identify and collect information useful for the extensive, technical, market-oriented, and commercial life science instrumentation market study. It was also used to obtain important information on key players, market classification & segmentation aligned with industry trends to the bottom-most level, and key developments from market and technology perspectives. A database of the key industry leaders was also prepared using secondary research.

    Primary Research

    In the primary research process, various supply and demand sources were interviewed to obtain qualitative and quantitative information for this report. The primary sources on the supply side include industry experts such as CEOs, vice presidents, marketing and sales directors, technology & innovation directors, and other key executives from leading companies and organizations in the life science instrumentation market. The demand-side primary sources include pharma-biopharma companies, CDMOs, research labs, F&B companies, and service providers. Primary research was conducted to validate the market segmentation, identify key players, and gather insights on key industry trends & key market dynamics.

    Life Science Instrumentation Market 
 Size, and Share

    Others include sales managers, marketing managers, business development managers, product managers, distributors, and suppliers.
    Note: Companies are classified into tiers based on their total revenue. As of 2025, Tier 1 = >USD 4 billion, Tier 2 = USD 1-2 Billion, and Tier 3 = <USD 1 Billion.

    To know about the assumptions considered for the study, download the pdf brochure

    Market Size Estimation

    In this report, the life science instrumentation market size was determined using the revenue share analysis of leading players. For this purpose, key market players were identified, and their revenues from the market were determined using insights gathered during the primary and secondary research phases. Secondary research included analyzing the annual and financial reports of the top market players. In contrast, primary research included extensive interviews with key opinion leaders, including CEOs, directors, and senior marketing executives.

    Segmental revenues were calculated based on the revenue mapping of major solution/service providers to calculate the global market value. This process involved the following steps:

    • Generating a list of major global players operating in the life science instrumentation market
    • Mapping annual revenues generated by major global players from the technology segment (or nearest reported business unit/product category)
    • Revenue mapping of major players to cover a major share of the global market, as of 2025
    • Extrapolating the global value of the life science instrumentation market industry.

    Life Science Instrumentation Market Top Down and Bottom Up Approach

    Data Triangulation

    After arriving at the overall market size from the market size estimation process explained above, the global life science instrumentation market was split into segments and subsegments. Data triangulation and market breakdown procedures were employed to complete the overall market engineering process and arrive at the exact statistics for all segments and subsegments. The data was triangulated by studying various factors and trends from both the demand and supply sides. Additionally, the life science instrumentation market was validated using top-down and bottom-up approaches.

    Market Definition

    Life science techniques encompass a variety of analytical and experimental methodologies including chromatography, spectroscopy, electrophoresis, PCR, and flow cytometry used to study living organisms. These techniques have broad applications across pharmaceuticals and biotechnology, clinical diagnostics, food and beverage testing, environmental monitoring, and industrial chemistry. They are also widely utilized by academic and research institutions as well as forensic laboratories. Overall, these technologies enable scientists to analyze and understand cellular functions and biological systems more effectively.

    Key Stakeholders

    • Product Manufacturers, Distributors, and Suppliers
    • Biotechnology and Pharmaceutical Companies and CROs
    • Laboratory Technicians and Workers
    • Life Science Instruments Manufacturers, Vendors, and Distributors
    • Venture Capitalists and Other Government Funding Organizations
    • Research and Consulting Firms
    • Healthcare Equipment or Product Suppliers and Distributors
    • Group Purchasing Organizations (GPOs)
    • Academic Universities and Medical Research Centers
    • Environmental Testing Laboratories
    • Food and Beverage Testing Centers
    • Hospitals and Diagnostic Centers
    • Clinical Research Organizations
    • R&D Centers
    • Business Research and Consulting Firms
    • Medical Research Laboratories
    • R&D Departments
    • Finance/Procurement Departments

    Report Objectives

    • To define, describe, and forecast the size of the life science instrumentation market based on technology, application, end user, and region
    • To provide detailed information regarding the major factors influencing the growth potential of the global life science instrumentation market (drivers, restraints, opportunities, challenges, and trends)
    • To analyze the micromarkets with respect to individual growth trends, prospects, and contributions to the global life science instrumentation market
    • To analyze key growth opportunities in the global life science instrumentation market for key stakeholders and provide details of the competitive landscape for market leaders
    • To forecast the size of market segments and/or subsegments with respect to five major regions: North America (US and Canada), Europe (Germany, France, the UK, Italy, Spain, and the RoE), Asia Pacific (Japan, China, India, Australia, South Korea, and the RoAPAC), Latin America (Brazil, Mexico, and the RoLATAM), and the Middle East & Africa
    • To profile the key players in the life science instrumentation market and comprehensively analyze their market shares and core competencies
    • To track and analyze the competitive developments undertaken in the global life science instrumentation market, such as product launches, agreements, expansions, and mergers & acquisitions

    Available customizations:

    Based on the given market data, MarketsandMarkets offers customizations tailored to the company’s specific needs. The following customization options are available for the present global life science instrumentation market report:

    Product Analysis

    • Product matrix, which gives a detailed comparison of the product portfolios of the top five companies

    Company Information

    • Detailed analysis and profiling of additional market players (up to five)

     

    Get the Full Life Science Instrumentation Market Report

    Full forecast, segment splits, and company analysis for all Life Science Instrumentation Market.

    Need a Tailored Report?

    Customize this report to your needs

    Get 10% FREE Customization

    Customize This Report
    Fact checked
    DMCA.com Protection Status